<VariationArchive VariationID="434688" VariationName="NM_004364.5(CEBPA):c.332_339del (p.Ala111fs)" VariationType="Deletion" Accession="VCV000434688" Version="8" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-04" DateCreated="2017-08-28" MostRecentSubmission="2020-12-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="430173" VariationID="434688">
      <GeneList>
        <Gene Symbol="CEBPA" FullName="CCAAT enhancer binding protein alpha" GeneID="1050" HGNC_ID="HGNC:1833" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19q13.11</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="33299934" stop="33302534" display_start="33299934" display_stop="33302534" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="33790839" stop="33793429" display_start="33790839" display_stop="33793429" Strand="-" />
          </Location>
          <OMIM>116897</OMIM>
          <Haploinsufficiency last_evaluated="2022-06-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CEBPA">No evidence available</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-06-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CEBPA">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_004364.5(CEBPA):c.332_339del (p.Ala111fs)</Name>
      <CanonicalSPDI>NC_000019.10:33302075:CGCGGGCGCGC:CGC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>19q13.11</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="33302076" stop="33302083" display_start="33302076" display_stop="33302083" variantLength="8" positionVCF="33302075" referenceAlleleVCF="CCGCGGGCG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="33792982" stop="33792989" display_start="33792982" display_stop="33792989" variantLength="8" positionVCF="33792981" referenceAlleleVCF="CCGCGGGCG" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>A111fs</ProteinChange>
      <ProteinChange>A97fs</ProteinChange>
      <ProteinChange>A146fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.33302079_33302086del" Assembly="GRCh38">
            <Expression>NC_000019.10:g.33302079_33302086del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.33792985_33792992del" Assembly="GRCh37">
            <Expression>NC_000019.9:g.33792985_33792992del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012022.1" sequenceAccession="NG_012022" sequenceVersion="1" change="g.5442_5449del">
            <Expression>NG_012022.1:g.5442_5449del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001285829.2" sequenceAccession="NM_001285829" sequenceVersion="2" change="c.-26_-19del">
            <Expression>NM_001285829.2:c.-26_-19del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001287424.2" sequenceAccession="NM_001287424" sequenceVersion="2" change="c.437_444del">
            <Expression>NM_001287424.2:c.437_444del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001274353.1" sequenceAccession="NP_001274353" sequenceVersion="1" change="p.Ala146fs">
            <Expression>NP_001274353.1:p.Ala146fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001287435.2" sequenceAccession="NM_001287435" sequenceVersion="2" change="c.290_297del">
            <Expression>NM_001287435.2:c.290_297del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001274364.1" sequenceAccession="NP_001274364" sequenceVersion="1" change="p.Ala97fs">
            <Expression>NP_001274364.1:p.Ala97fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004364.5" sequenceAccession="NM_004364" sequenceVersion="5" change="c.332_339del" MANESelect="true">
            <Expression>NM_004364.5:c.332_339del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004355.2" sequenceAccession="NP_004355" sequenceVersion="2" change="p.Ala111fs">
            <Expression>NP_004355.2:p.Ala111fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_456" sequenceAccession="LRG_456">
            <Expression>LRG_456:g.5442_5449del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA645373269" DB="ClinGen" />
        <XRef Type="rs" ID="1555742213" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004364.5(CEBPA):c.332_339del (p.Ala111fs) AND Acute myeloid leukemia" Accession="RCV000502416" Version="7">
        <ClassifiedConditionList TraitSetID="6288">
          <ClassifiedCondition DB="MedGen" ID="C0023467">Acute myeloid leukemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-04-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004364.5(CEBPA):c.332_339del (p.Ala111fs) AND not provided" Accession="RCV001269596" Version="4">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-07-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2017-07-14" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2017-08-28" MostRecentSubmission="2020-12-11">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6288" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="15736" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Leukemia, acute myeloid, somatic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Leukemia, acute myelogenous, somatic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Acute myeloid leukemia</ElementValue>
                <XRef ID="HP:0004808" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0018874" DB="MONDO" />
                <XRef ID="519" DB="Orphanet" />
                <XRef ID="17788007" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acute myeloid leukemia, adult</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">AML adult</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acute myelogenous leukemia</ElementValue>
                <XRef ID="Acute+Myeloid+Leukemia%2C+Adult/204" DB="Genetic Alliance" />
                <XRef ID="HP:0004808" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acute non-lymphocytic leukemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acute granulocytic leukemia</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">AML</ElementValue>
                <XRef ID="GTR000500636" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="601626" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12757" />
                <XRef ID="12757" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism">Constitutively activated FLT3</Attribute>
                <XRef ID="GTR000552464" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">A clonal expansion of myeloid blasts in the bone marrow, blood or other tissues. The classification of acute myeloid leukemias (AMLs) encompasses four major categories: 1) AML with recurrent genetic abnormalities; 2) AML with multilineage dysplasia; 3) Therapy-related AML; 4) AML not otherwise specified. The required bone marrow or peripheral blood blast percentage for the diagnosis of AML is 20% (WHO classification)</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20963938</ID>
                <ID Source="BookShelf">NBK47457</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="NCCN, 2011">
                <ID Source="PubMed">22138009</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESMO, 2013">
                <ID Source="PubMed">23970018</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">33226740</ID>
                <ID Source="BookShelf">NBK564234</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">33661592</ID>
                <ID Source="BookShelf">NBK568319</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">34723452</ID>
                <ID Source="BookShelf">NBK574843</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESMO, 2020">
                <ID Source="PubMed">32171751</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2023">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/all.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Acute Lymphoblastic Leukemia, 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2023">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/aml.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Acute Myeloid Leukemia, 2023</CitationText>
              </Citation>
              <XRef ID="519" DB="Orphanet" />
              <XRef ID="C0023467" DB="MedGen" />
              <XRef ID="D015470" DB="MeSH" />
              <XRef ID="MONDO:0018874" DB="MONDO" />
              <XRef Type="MIM" ID="601626" DB="OMIM" />
              <XRef Type="primary" ID="HP:0004808" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0001914" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0004843" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0005516" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0006724" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0006728" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1150444" SubmissionDate="2017-07-05" DateLastUpdated="2017-08-28" DateCreated="2017-08-28">
        <ClinVarSubmissionID localKey="NM_004364.3(CEBPA):c.332_339del|Leukemia, acute myeloid" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000594000" DateUpdated="2017-08-28" DateCreated="2017-08-28" Type="SCV" Version="1" SubmitterName="Genetic Services Laboratory, University of Chicago" OrgID="1238" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-04-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CEBPA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004364.3:c.332_339del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Leukemia, acute myeloid</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB2843028</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2862557" SubmissionDate="2020-11-26" DateLastUpdated="2020-12-11" DateCreated="2020-12-11">
        <ClinVarSubmissionID localKey="NM_004364.5:c.332_339del|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001449691" DateUpdated="2020-12-11" DateCreated="2020-12-11" Type="SCV" Version="1" SubmitterName="Clinical Genetics and Genomics, Karolinska University Hospital" OrgID="505315" OrganizationCategory="laboratory" OrgAbbreviation="KLINGEN-KUS" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-07-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CEBPA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004364.5:c.332_339del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8639822</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2862557" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1150444" TraitType="Disease" MappingType="Name" MappingValue="Leukemia, acute myeloid" MappingRef="Preferred">
        <MedGen CUI="C0023467" Name="Acute myeloid leukemia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

